Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Lee Schwartzberg MD, FACP
Lee S. Schwartzberg MD, FACP Advisory Board
Barbara Burtness MD
Barbara Burtness MD Advisory Board
Rafael Fonseca MD
Rafael Fonseca MD Editor-in-Chief
See All Experts
Published in Oncology

Journal Scan / Research · April 07, 2023

Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On/After ICIs or Chemotherapy

Journal of Thoracic Oncology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Rodrigo Fonseca MD

Journal of Thoracic Oncology
MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Non-Squamous Non-Small Cell Lung Cancer Progressing On/After Checkpoint Inhibitor Therapy or Chemotherapy
J Thorac Oncol 2023 Feb 24;[EPub Ahead of Print], K He, D Berz, SM Gadgeel, WT Iams, DS Bruno, CM Blakely, AI Spira, MR Patel, DM Waterhouse, DA Richards, A Pham, R Jotte, DS Hong, EB Garon, A Traynor, P Olson, L Latven, X Yan, R Shazer, TA Leal

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated